Patents by Inventor Nalinkant C. Damani

Nalinkant C. Damani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5560921
    Abstract: The present invention relates to immediate release compositions comprising a pre-complex comprising a polymeric polycarboxylate and an aminophenylalkanol vasoconstrictor in a solid chewable matrix of pharmaceutically-acceptable carrier ingredients wherein the aminophenylalkanol vasoconstrictor and polymeric polycarboxylate are in a weight ratio of from about 5:1 to about 1:10 and wherein the pre-complex is dissociable at a pH of from about 4.5 to about 6.8, releasing the aminophenylalkanol vasoconstrictor.
    Type: Grant
    Filed: April 28, 1995
    Date of Patent: October 1, 1996
    Assignee: The Procter & Gamble Company
    Inventors: Nalinkant C. Damani, Rita Vienhues
  • Patent number: 5447725
    Abstract: Methods for aiding periodontal tissue regeneration with compositions containing bioresorbable polymers, leachable solvents, and bioavailable drug actives. The compositions useful for these methods are characterized by becoming harder upon contact with the periodontal tissue such that the composition is effective for aiding tissue regeneration and by releasing a therapeutically-effective amount of drug active agent.
    Type: Grant
    Filed: June 11, 1993
    Date of Patent: September 5, 1995
    Assignee: The Procter & Gamble Company
    Inventors: Nalinkant C. Damani, Douglas C. Mohl, Robert E. Singer, Jr.
  • Patent number: 5286489
    Abstract: This disclosure relates to drug-polymer matrix compositions comprising an active ingredient having an amine or amido group and a pharmaceutically acceptable copolymer having a plurality of carboxylic acid and ester groups wherein the matrix dissociates in a media having a pH of less than 4, thereby releasing the active ingredient into the media.
    Type: Grant
    Filed: March 16, 1993
    Date of Patent: February 15, 1994
    Assignee: The Procter & Gamble Company
    Inventors: Josef H. Tsau, Nalinkant C. Damani
  • Patent number: 5262164
    Abstract: This invention relates to compositions and methods for treating diseases of the oral cavity in humans and lower animals using a glycerol monooleate gel for releasing drugs in the oral cavity.
    Type: Grant
    Filed: November 17, 1989
    Date of Patent: November 16, 1993
    Assignee: The Procter & Gamble Company
    Inventor: Nalinkant C. Damani
  • Patent number: 5198220
    Abstract: This invention relates to compositions/devices and methods for treating diseases of the oral cavity in humans and lower animals using polylactide/glycolide compositions/devices for releasing drugs in the oral cavity.
    Type: Grant
    Filed: August 24, 1990
    Date of Patent: March 30, 1993
    Assignee: The Procter & Gamble Company
    Inventor: Nalinkant C. Damani
  • Patent number: 5173299
    Abstract: This invention relates to compositions/devices and methods for treating diseases of the oral cavity in humans and lower animals using polypropenoic acid compositions/devices for releasing drugs in the oral cavity.
    Type: Grant
    Filed: October 7, 1991
    Date of Patent: December 22, 1992
    Assignee: The Procter & Gamble Company
    Inventor: Nalinkant C. Damani
  • Patent number: 5114718
    Abstract: This invention relates to devices/compositions and methods for treating diseases of the oral cavity in humans and lower animals using non-biodegradable devices/compositions which are biocompatible but not bioerodible for releasing drugs in or around a periodontol pocket or gingival sulcus.
    Type: Grant
    Filed: September 20, 1990
    Date of Patent: May 19, 1992
    Assignee: The Procter & Gamble Company
    Inventor: Nalinkant C. Damani
  • Patent number: 5084267
    Abstract: This invention relates to compositions/devices and methods for treating diseases of the oral cavity in humans and lower animals using polypropenoic acid compositions/devices for releasing drugs in the oral cavity.
    Type: Grant
    Filed: November 17, 1989
    Date of Patent: January 28, 1992
    Assignee: The Procter & Gamble Company
    Inventor: Nalinkant C. Damani
  • Patent number: 4971791
    Abstract: This disclosure relates to drug-polymer matrix compositions comprising an active ingredient having an amine or amido group and a pharmaceutically acceptable copolymer having a plurality of carboxylic acid and ester groups wherein the matrix dissociates in a media having a pH of less than 4, thereby releasing the active ingredient into the media.
    Type: Grant
    Filed: May 1, 1990
    Date of Patent: November 20, 1990
    Assignee: The Procter & Gamble Company
    Inventors: Josef H. Tsau, Nalinkant C. Damani
  • Patent number: 4892890
    Abstract: The present disclosure relates to an external analgesic solid stick composition for the topical administration of active analgesic agents. The compositions are dimensionally stable solid compositions comprising an external analgesic agent incorporated into a non-reactive hydrophobic wax matrix.
    Type: Grant
    Filed: May 5, 1986
    Date of Patent: January 9, 1990
    Assignee: G. D. Searle and Company
    Inventor: Nalinkant C. Damani
  • Patent number: 4514385
    Abstract: Anti-acne preparations include finely divided, dispersed particles of benzoyl peroxide and finely divided, dispersed particles of salicylic acid in an aqueous gel formed from carboxy vinyl polymer resins. The gels are prepared without loss of salicylic acid by fully hydrating the resin in an aqueous medium and allowing the resin to gel in the absence of an alkaline neutralizing agent.
    Type: Grant
    Filed: October 5, 1981
    Date of Patent: April 30, 1985
    Assignee: Alcon Laboratories, Inc.
    Inventors: Nalinkant C. Damani, Haresh G. Bhagat, Ramon L. McElhaney
  • Patent number: 4016880
    Abstract: Osmotically driven active agent dispenser for use in an aqueous environment that pumps a solution of active agent, such as a drug, at a predetermined, constant rate. The dispenser is in the form of a coated tablet comprising: a core of an osmotically effective active agent composition; and an inexpandable wall that encloses the core, has a controlled permeability to water and includes means, such as brittleness or sites of structural weakness, that is responsive to the pressure generated within the dispenser by imbibition of water from the environment by the core through the wall to form at least one, and usually many, passageways in situ in the wall through which the active agent composition in solution is pumped osmotically at a rate that is substantially dependent of the rate at which water is being imbibed into the dispenser.
    Type: Grant
    Filed: March 4, 1976
    Date of Patent: April 12, 1977
    Assignee: Alza Corporation
    Inventors: Felix Theeuwes, Nalinkant C. Damani
  • Patent number: 3971377
    Abstract: A process for dispensing medicaments in aerosol form for inhalation therapy is disclosed. The process comprises: providing a hollow elongate housing having air inlet and air outlet passages; generating a positive pressure, air-stream between the inlet and outlet passages; rotationally releasing medicament from a container within the housing into the air-stream; and inserting the outlet passage into the oral or nasal cavity of the patient.
    Type: Grant
    Filed: July 21, 1975
    Date of Patent: July 27, 1976
    Assignee: Alza Corporation
    Inventor: Nalinkant C. Damani